We investigated a possible involvement of nitric oxide formed by inducible nitric oxide synthase (iNOS) in the signaling cascade leading to growth inhibition and differentiation in the human neuroblastoma cell line SK-N-SII. Treatment of SK-N-SH with interferon-γ (IFN-γ) plus interleukin-lß (IL-lß) led to induction of iNOS, growth inhibition and an altered cell shape. However two inhibitors of iNOS were not able to prevent cytokine induced changes. In addition, IFN-γ alone led to growth inhibition in absence of iNOS induction. Inhibition of the induced indoleamine 2,3-dioxygenase (IDO) activity also did not prevent growth inhibition. Our finding show that mechanisms other than NO and IDO can control interferon-y-induced growth inhibition of SK-N-SH cells.
Introduction
neuroblastoma, nitric oxide synthase, interferon-γ, interleukin-1-ß Nitric oxide (NO) is endogenously produced in cells by different isoforms of the enzyme nitric oxide synthase (NOS), which converts arginine to citrulline and NO in the presence of oxygen ( 1 ) . NO has a broad variety of effects as signalling agent. This includes the ability of NO to influence and to control cell growth and differentiation. In PC 12 rat neuronal cells, NO induces growth arrest followed by differentiation after treatment with nerve growth factor (NGF), whereas N-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, prevents growth arrest (2) . In primary cultures of murine cortical neurons, as well as in embryonic stem cell-derived neurons, the NO dorior detaNONOate promotes differentiation observed as an enhanced neurite outgrowth (3) . Inhibition of NO formation reduced the outgrowth of neurites in these cells. In primary cultures of rat brown fat precursor cells NO stops proliferation and induces differentiation to brown adipocytes (4) . In Drosophila NO is involved in the control of the development of organs and strucindoleamine 2,3-dioxygenase, tures in the imaginai disc (5, 6) , in the development of the eye and in the formation of ordered neuronal connections in the visual system of the fly (7).
The human cell line SK-N-SH was derived from a metastatic site in the bone marrow of a patient suffering from neuroblastoma (8) . The cell line consists of two different cell types showing small round cells with thin neurite-like processes (N-type) and large epithelial-like cells (S-type). Both cell types have the same precursor and are able to convert into one another. This conversion of the two cell types into each other was described as "transdifferentation" (9) . SK-N-SH cells exhibit neuronal properties. Neuronal differentiation can be affected with stimuli like retinole acid or 4ß-phorbol 12-myristate 13-acetate (10) . Also TNF-a (11 ) and infection with HIV-1 (12) were reported to affect differentiation of SK-N-SH in an NO dependent manner. Here we investigated whether NO is an essential mediator for differentiation in SK-N-SH in response to pro-inflammatory cytokines.
The human neuroblastoma line SK-N-SH obtained from ATCC (American Type Culture Collection) was grown in MEM (Eagle) with Earle's salts (Biochrom, Berlin, Germany) adjusted to contain 1.5 g/L sodium bicarbonate supplemented with 2 mM L-glutamine (Sigma, Vienna, Austria), 1 mM sodium pyruvate (Biochrom), 0.1 mM non-essential amino acids (Sigma) and 10% (v/v) heat-inactivated fetal calf serum (Biochrom) at 37°C in an atmosphere of 5% C0 2 . Where indicated, cells were treated with interferon-γ (IFN-γ, kindly provided by R. E. Rentschler Biotechnologie, Laupheim, Germany), interleukin-lß (IL-lß, Sigma, Vienna, Austria), N'-iminoethyl-L-lysine (L-NIL, Alexis, Vienna, Austria), NG-methyl-Larginin (L-NMA, Sigma, Vienna, Austria), N°-hydroxy-nor-L-arginine (nor-NOHA, Alexis, Vienna, Austria), methyl-D-tryptophan (1-MT, Sigma, Vienna, Austria).
RNA isolation, reverse transcription and real-time PCR
Total RNA was isolated from cells by the use of TRIzol Reagent (Invitrogen). From 500 ng of total RNA, cDNA was prepared with random hexamer primers using Superscript II RNase Η-reverse transcriptase (Invitrogen). Real-time PCR (Taqman technology) was performed with a AbiPrism 7700 sequence detector (Applied Biosystems, Foster City CA, USA) using the Brilliant Quantitative PCR Core Kit (Stratagene, Amsterdam, The Netherlands). Probes (5'-6-carboxyfluorescein (FAM)/3'-6-carboxy-tetramethylrhodamine (TAMRA) label) and primers were designed with the Primer Express Software (Applied Biosystems). Sequences (5'-3' direction) were as follows: human iNOS: primer forward: CCAACAATGGCAACAT-CAGG, primer reverse:
TCGTGCTTGCCAT-CACTCC, probe: FAM-CGGCCATCAC-CGTGTTCCCC-TAMRA, human 200kD neurofilament: primer forward: AGGCCGACATTGCCTCC, primer reverse: GGTGTTCCTCAGCTCAGCG, probe:
FAM-ACCAGGAAGCCATTCAGCA-GCTGG-TAMRA, human IDO: primer forward: and for 18 S rRNA: primer forward: CCATTCGA-ACGTCTGCCCTAT, primer reverse: TCACC-CGTGGTCACCATG, probe: FAM-ACTTTC-GATGGTAGTCGCCGTGCCT-TAMRA. Levels of mRNAs were related to 18 S ribosomal RNA levels.
Western Blot Analysis
Cell lysates of control and stimulated cells were separated by SDS/PAGE. Proteins were transferred to PVDF membranes (Hybond-P, Amersham) by standard procedures. Primary iNOS antibody (Transduction Laboratories) was diluted 1:10000 in PBS containing 0,1 % (w/v) Tween 20. A secondary peroxidase-conjugated anti-mouse antibody (Sigma) was diluted 1:50000. Bands were detected with the ECL+ reagent (Amersham-Pharmacia).
Determination of nitrite and nitrate
Nitrite and nitrate levels were measured by HPLC. Samples of culture supernatant were applied to a reversed-phase C18 column (Lichrosphere, 5μηι particle size, 250 mm χ 4 mm, Merck, Darmstadt, Germany) and eluted with 2% ammonium-acetate (pH 7.0). Nitrate was reduced to nitrite by a cadmium column (cadmium 0.3-0.8 mm, 20-50 mesh ASTM, Merck, packed into a Pharmacia HR 5/5 glass column). Nitrite was quantified after post-column mixing with the Griess reagent and heating to 60°C in a 10 m capillary by measuring optical density at 546 nm.
Determination of tryptophan and kynurenine
For sample preparation, 100 μΐ of each sample was diluted with 100 μΐ of 50 μπιοΐ/ΐ 3-nitro-L-tyrosine (Sigma) which served as an internal standard. After addition of 25 μΐ of 2 mol/1 trichloroacetic acid (Merck) samples were centrifuged at 12000 g for 6 min at room temperature to remove the protein. For separation, a reversed-phase LiChroCART 55-4 cartridge (Merck) filled with Purosphere STAR RP18 (3 μττι grain size, Merck) together with a reversed-phase C18 precolumn was used. The elution buffer contained 15 mmol/1 acetic acid-sodium acetate (pH 4.0) and 27 ml/1 acetonitrile (13).
Cell Proliferation Assay
Cell proliferation was determined with the CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega, Mannheim, Germany). This is a colorimetrie method based on the bioreduction of (3-(4,5-dimethylthiazol-2-yl-)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) by viable cells to a soluble formazan that can be measured directly in the culture medium. Cells were incu-bated for 2 h with an MTS/phenazine methosulfate (PMS) solution and the optical density was measured at 490 nm.
Results
Treatment of SK-N-SH cells with a combination of IFN-γ plus IL-lß, a mixture known to stimulate NO formation in hepatocytes (14) , led to induction of iNOS mRNA expression (measured after a 6 h incubation). Transcription of iNOS mRNA in stimulated cells was dose-dependent and a combination of 1000 U/ml IFN-γ and 0.5 ng/ml IL-lß turned out to be most efficient after a 6 h incubation. Single stimuli showed no effect on iNOS mRNA levels (Fig. 1) . Although no effect on iNOS m RNA levels (Fig. 1) ly low and no iNOS protein could be detected two days after stimulation. Furthermore no nitrite plus nitrate release into the medium five days after stimulation could be observed due to sensitivity limitations. It is known that the production of NO is limited by the level of L-arginine, the substrate of iNOS. Depletion of arginine by the cellular enzyme arginase suppresses not only enzyme activity but also translation of the iNOS protein (15) . We used the specific inhibitor of arginase, NG-Hydroxy-nor-L-Arginin to overcome a possible depletion of arginine before the cells gain the ability to produce NO. Doses between 5 and 500 μΜ were used to treat 2.5x10 4 cells/ml. In addition, the medium was supplemented with 1 mM L-arginine. However, these attempts did not yield detectable increase of nitrite plus nitrate in medium of stimulated cells (data not shown).
Nevertheless incubation of the cells with IFN-γ plus IL-1 β for 5 days caused a dramatic change in morphology (Fig. 2) . Treatment with IFN-γ plus IL-1 β, but also with IFN-γ alone, inhibited proliferation of the cells. Control cells and cells treated with IL-1 β alone grew to confluency, whereas cells treated with IFN-γ with or without IL-1 β remained subconfluent. Cells treated with the combination of IFN-γ and IL-IB appeared long shaped with a high number of cells showing processes. Also IL-1 β treated cells seemed long shaped. Compared to unstimulated cells, cells treated with IFN-γ alone exhibited no morphological changes besides the growth inhibition, and remained viable for at least another 5 days in culture. To ensure that the observed changes were not mediated by low levels of NO, not detectable by our HPLC system, stimulated cells were exposed to two inhibitors of iNOS. Treatment with 500 μΜ of L-NIL or L-NMA was not able to prevent the cytokine effect on the cellular appearance. When the inhibitors were added to the cells without cytokines no effect on the appearance and growth of the cells was observed. Cell proliferation was inhibited when cells were treated with a combination of IFN-γ plus IL-1 β (Fig. 3A) . Different dosages of iNOS inhibitors used in this experiment were not able to overcome this growth inhibition. The proliferation restriction caused by IFN-γ alone was also not influenced by the inhibitors (Fig. 3B) . To detect a possible neuronal differentiation, 200 kD neurofilament mRNA levels were quantified over a four day time-course in unstimulated control cells and in cells treated with IFN-γ plus IL-1 β. No rise in 200 kD neurofilament mRNA could be found in stimulated cells compared to control. Although strong morphological changes were observed, this finding argues against a neuronal differentiation triggered by the cytokines. In addition, only the flat epithelioid cell type seemed to be affected by the cytokines, whereas the small cell type known for its neuronal properties looked whether a possible depletion of tryptophan in the culture medium, caused by IDO induction, was responsible for the growth inhibition. A strong induction of IDO mRNA in response to cytokine treatment was confirmed by real-time PCR (Fig. 1) . In an attempt to overcome the IFN-y-induced growth inhibition, 1 -methyl-tryptophan, a specific inhibitor of IDO, was used. 100 μΜ and 500 μΜ were able to reduce IDO activity, which was measured as depletion of tryptophan and accumulation of kynurenine in culture supernatants (Fig. 3C ), but did not attenuate the growth inhibition (Fig. 3B) . Medium of cells in which IFN-γ-plus IL-lß induced growth inhibition still contained approximately half of the original tryptophan (Fig. 3C) . We conclude therefore that the absence of tryptophan cannot be the cause for the stopped cell growth.
Discussion
It was supposed that NO plays a crucial role in mediating and controlling differentiation. It has been reported that TNF-a (11) and infection with HIV-1 (12) triggers differentiation of SK-N-SH neuroblastoma cells through stimulating of iNOS. In this work we investigated the effect of two cytokines on this cell type. We showed that IFN-γ plus IL-lß as well as IFN-γ alone caused SK-N-SH cells to cease proliferation. The combination of the two cytokines led to dramatic morphological alterations of stimulated cells compared to untreated cells. However, despite a distinct increase of iNOS m RNA, we did not detect the formation of NO although we ensured the presence of sufficient arginine, the substrate of iNOS. In addition it was not possible to prevent the changes of cytokine treated cells by high doses of inhibitors of NOS. Furthermore, IFN-γ alone was able to force the cells to stop proliferation, but did not induce iNOS transcription in SK-N-SH. The observed growth inhibition and morphological changes of IFN-γ plus IL-lß treated cells suggest that a differentiation of the epithelioid cells occurs, but our findings argue against an involvement of NO. These results differ from previous findings of effects of TNF-a on SK-N-SH (11). In our hands, TNF-a could not induce iNOS mRNA in SK-N-SH, which we had genotyped to confirm cell line identity (18) . In addition, we confirmed that our TNF-α preparation had biological activity on our SK-N-SH cells by its effect on GTP-cycIohydrolase I mRNA expression in the same specimens that lacked iNOS induction (data not shown). The differentiation seems not to be a neuronal one, because no rise in 200 kD neurofilament mRNA was found and the small cells with a neurite appearance were not affected by the cytokines. We could also show that depletion of tryptophan in the culture medium by induction of indoleamine 2,3-dioxygenase was not the cause of the growth inhibition.
A variety of cells like human colon carcinoma cells (19) , human airway smooth muscle cells (20) , glioblastoma cells (21) and mesothelioma cells (22) cease proliferation after treatment with IFN-γ. The mechanism which leads to growth arrest is not fully understood and seems to vary between different cell types. In human fibrosarcoma cells IFN-γ triggered growth arrest is caused by STATI activated expression of p21(Wafl/Cipl), which is a repressor of cyclinedependent kinase, and inhibits cell proliferation by blocking the cell cycle progression (23) .
It remains to be determined, whether a similar mechanism is responsible for IFN-γ mediated growth arrest in SK-N-SH.
